Search

Dora Bocangel Wiederhold

from League City, TX
Age ~55
Get Report
Also known as:
Dora B Wiederhold, Dora Beatriz Bocangel, Dora B Bocangel, Dora L Montestruque, Dora M Montestruque, Dora Beatriz L, Dora L
Phone and address:
6189 Derby Ct, League City, TX 77573
(281) 796-2604
Related to:
James C Wiederhold, 66Beverly H Dehaven, 77Arlene A Wiederhold, 72Dora L HinesWiederhold R Lee, 50Martha M HinesGeorge A HinesCarolina Montestruque, 45Lee Wiederhold, 50Robert M Hines, 77Dora Montestruque, 74Paco Montestruque, 53Dorothy M Wiederhold, 85Hamblin DebeverlySilvia B Montestruque, 78Amanda J Wiederhold, 45Carolina A Sabogal, 45Dora Montestruque
Connected to:
Anita C Wiederkehr, 86Annette E Wiederkehr, 58Aubrey M Wiederin, 28Barbara A Wiederholt, 86Brad J Wiederholt, 57Bruce H Wiederholt, 61Casey A Wiederhold, 38Christopher L Wiederholt, 63Danny Wiederkehr, 41Erich T Wiederhold, 55

Dora Wiederhold Phones & Addresses

  • 6189 Derby Ct, League City, TX 77573 (281) 796-2604
  • Dime Box, TX
  • Pearland, TX
  • Houston, TX
  • Ventura, CA
  • Galveston, TX
  • Camarillo, CA
  • San Diego, CA
  • 6189 Derby Ct, League City, TX 77573

Work

Company: Md anderson cancer center Position: Manager clinical research protocol

Industries

Hospital & Health Care

Resumes

Resumes

Dora Wiederhold Photo 1

Manager Clinical Research Protocol At Md Anderson Cancer Center

View page
Position:
Manager Clinical Research Protocol at MD Anderson Cancer Center
Location:
Houston, Texas Area
Industry:
Hospital & Health Care
Work:
MD Anderson Cancer Center
Manager Clinical Research Protocol
Introgen Therapeutics, Inc. 2005 - 2008
Scientist, Clinical Research and Development

Business Records

Name / Title
Company / Classification
Phones & Addresses
Dora Wiederhold
Managing M, Managing
DRAGONFLY SCIENCE CONSULTANTS, LLC
6189 Derby Ct, League City, TX 77573
Dora Wiederhold
Treasurer, Director
WILLOW LAKE ESTATES HOMEOWNERS ASSOCIATION, INC
4760 Preston Rd STE 244 C/O PMB 238, Frisco, TX 75034
18333 Egret Bay Blvd, Houston, TX 77058
17049 El Camino Real, Houston, TX 77058

Publications

Us Patents

Methods And Compositions Comprising Tumor Suppressor Gene Therapy And Cd122/Cd132 Agonists For The Treatment Of Cancer

View page
US Patent:
20210094991, Apr 1, 2021
Filed:
Mar 19, 2019
Appl. No.:
15/733619
Inventors:
- Houston TX, US
Kerstin B. MENANDER - Houston TX, US
Dora WIEDERHOLD - Houston TX, US
Sunil CHADA - Houston TX, US
Assignee:
MULTIVIR INC. - Houston TX
International Classification:
C07K 14/47
A61P 35/00
A61K 35/768
C07K 14/54
C12N 15/86
Abstract:
Provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of at least one CD 122/CD 132 agonist, at least one immune checkpoint inhibitor and a viral composition comprising one or more viruses engineered to overexpress a tumor suppressor gene and/or an adenoviral death protein. Also provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of at least one oncolytic viral composition and at least one CD122/CD132 agonist and at least one immune checkpoint inhibitor. Also provided herein are methods of enhancing anti-tumor efficacy by administering the agents described above in combination with other cancer therapies. In highly aggressive forms of cancer, known to be generally resistant to immune therapies, these treatments unexpectedly resulted in complete tumor remissions and curative outcomes.

Methods And Compositions Comprising Viral Gene Therapy And An Immune Checkpoint Inhibitor For Treatment And Prevention Of Cancer And Infectious Diseases

View page
US Patent:
20200009203, Jan 9, 2020
Filed:
Dec 12, 2017
Appl. No.:
16/468408
Inventors:
- Houston TX, US
Kerstin B. MENANDER - Bellaire TX, US
Dora WIEDERHOLD - Houston TX, US
Sunil CHADA - Missouri City TX, US
Assignee:
MULTIVIR INC. - Houston TX
International Classification:
A61K 35/761
A61K 39/395
C12N 7/00
A61K 38/19
A61K 38/22
A61K 38/44
A61K 38/16
A61K 35/763
A61K 31/513
A61K 31/7068
A61P 35/00
A61K 38/20
A61K 45/06
A61K 38/21
Abstract:
Provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of at least one immune checkpoint inhibitor and a viral composition comprising one or more viruses engineered to comprise an N1L gene deletion, a matrix-degrading protein gene, an adenoviral death protein (ADP) gene, and/or a cytochrome p450 gene. Also provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of a viral composition comprising two or more viruses engineered to comprise an N1L gene deletion a matrix-degrading protein gene, an adenoviral death protein (ADP) gene, and/or a cytochrome p450 gene. Also provided herein are methods of enhancing antitumor efficacy by administering the agents described above in combination with other cancer therapies.
Control profile
Dora Bocangel Wiederhold from League City, TX, age ~55 Get Report